Johnson & Johnson Booster Shot May Bolster Immune Response, FDA Staff Says

Johnson & Johnson Booster Shot May Bolster Immune Response, FDA Staff Says
·2 min read

A booster shot of Johnson & Johnson ‘s Covid-19 vaccine administered two months after the first dose could be beneficial in strengthening recipients’ immunological response, the staff of the Food and Drug Administration said Wednesday. FDA staff cautioned, however, that the data was limited and hadn’t been independently verified by the agency. The data was provided by J&J (ticker: JNJ) ahead of an FDA advisory panel hearing that will determine whether to approve the company’s request for emergency use of its booster shot.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting